Top Markets
#1 Black Phoenix Black Phoenix +199.70%
#2 Islamic Coin Islamic Coin +158.01%
#3 Glidr Glidr +84.34%
#4 Gold Park Gold Park +54.36%
#5 BasedHype BasedHype +32.50%
#6 Akedo Akedo +26.93%
#7 Acurast Acurast +24.11%
#8 Cryptopia Cryptopia +21.67%
#9 Quantum Resistant Ledger Quantum Resistant Ledger +18.56%
#10 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +16.57%
Coin of the day
Black Phoenix Black Phoenix
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Advanced Oncotherapy plc Advanced Oncotherapy plc

Advanced Oncotherapy plc

AVO
Rang in Aktien #41676
Advanced Oncotherapy plc, alongside its affiliated entities, specializes in the... Advanced Oncotherapy plc, alongside its affiliated entities, specializes in the development, production, and distribution of sophisticated proton-based radiotherapy systems aimed at treating cancer. A key initiative for the company involves advancing its Linac Image Guided Hadron Technology (LIGHT) system, an innovative proton therapy solution specifically engineered for oncology applications. Furthermore, the firm oversees the management of properties within the healthcare sector. Its operational reach extends across the United Kingdom, Switzerland, and the United States. Established in 1994, the company was initially incorporated as CareCapital Group plc before adopting its current name, Advanced Oncotherapy PLC, in September 2012. Its principal offices are located in London, UK.
Aktienkurs
$0.00023508
Zuletzt synchronisiert: 2023-09-25
Marktkapitalisierung
$13.16K
Veränderung (1 Tag)
-0.24%
Veränderung (1 Jahr)
0.00%
Land
GB
Handel Advanced Oncotherapy plc (AVO)

Kategorie

Healthcare
P/B-Verhältnis für Advanced Oncotherapy plc (AVO)
P/B-Verhältnis zum 2026 TTM: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von Advanced Oncotherapy plc beträgt das aktuelle Kurs-Buchwert-Verhältnis (TTM) 0. Am Ende des Jahres 2026 lag das P/B-Verhältnis bei 0.
P/B-Verlauf für Advanced Oncotherapy plc von 2026 bis 2026
P/B-Verhältnis zum Jahresende
Jahr P/B-Verhältnis ändert
Nicht genügend Daten für die angegebenen Daten.
P/B-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/B-Verhältnis P/B-Verhältnis-Differenz Land
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 3.6048 -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 5.207 -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 2.0146 -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 2.6697 -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 4.8038 -
US